EWTX – edgewise therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Edgewise Therapeutics, Inc. (NASDAQ: EWTX) had its price target raised by analysts at Wedbush from $44.00 to $45.00. They now have an "outperform" rating on the stock.
Edgewise Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
Edgewise Therapeutics, Inc. (NASDAQ: EWTX) had its price target raised by analysts at Piper Sandler from $48.00 to $51.00. They now have an "overweight" rating on the stock.
Edgewise Therapeutics to Present on Sevasemten (EDG-5506) for Becker Muscular Dystrophy (Becker) at the 29th International Annual Congress of the World Muscle Society
Edgewise's EDG-7500 shows benefit in two obstructive HCM trials [Yahoo! Finance]
Form SC 13G/A Edgewise Therapeutics, Filed by: EcoR1 Capital, LLC
Form SC 13G/A Edgewise Therapeutics, Filed by: VIKING GLOBAL INVESTORS LP
Form SC 13G Edgewise Therapeutics, Filed by: BAKER BROS. ADVISORS LP
Form SC 13G/A Edgewise Therapeutics, Filed by: Flynn James E
Form SC 13D/A Edgewise Therapeutics, Filed by: ORBIMED ADVISORS LLC
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.